WEST PHARMACEUTICAL SERVICES
WSTNYSETrading Snapshot
- Day Range
- β
- 52-Week Range
- $223.83 β $404.85
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 70.4M
- Next Earnings
- 2026-10-29
Fundamentals Snapshot
- Annual Revenue
- $3.07B
- Last Q Revenue
- $872M
- P/E Ratio
- 51.3
- P/S Ratio
- 8.5x
- EPS (TTM)
- $7.98
- Dividend Yield
- 0.22%
- Dilution (1yr)
- β1.4%
WEST PHARMACEUTICAL SERVICES
WSTAbout WEST PHARMACEUTICAL SERVICES
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith β a cyclic olefin polymer used in vials, syringes, and cartridges β and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Latest News & Updates

West Pharmaceutical (WST) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of West Pharmaceutical (WST) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of it

WST Q3 Earnings Preview: Will HVP Strength Offset Vantage Weakness?
WST's Q3 earnings may benefit from strong HVP demand, biologics and GLP-1 growth, but West Vantage weakness and the SmartDose divestiture could weigh on sales.

Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharmaceutical???s biologics exposure, Annex 1 projects and delivery-device growth support prospects despite near-term headwinds.

West Declares Quarterly Dividend
EXTON, Pa., Oct. 19, 2026 /PRNewswire/ -- On October 19, 2026, the Board of Directors ofΒ West Pharmaceutical Services, Inc.Β (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declare

West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
West Pharmaceutical ServicesΒ WST shares have gained 36.1% year to date, significantly outperforming its industry's advancement of 7.8%. The rally reflects improving demand for high-value pharmaceutical packaging compone

West Pharmaceutical Services (NYSE:WST) Stock Price Crosses Above Two Hundred Day Moving Average β Time to Sell?
West Pharmaceutical Services, Inc. (NYSE: WST - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $330.99 and t